Company news
Grape King Bio Ltd. news in 2022
Grape King Bio Ltd.'s news releases, calls and decks from 2022, newest first.
Grape King Bio: Announcement of the Company obtains right-of-use assets from related parties
August 10, 2022
Announcement of the Company's Consolidated Financial Report for the second quarter of 2022 has been approved by the Board of Directors
August 10, 2022
Announcement of the record date decided for distribution of ex-dividend by the chairman.
May 27, 2022
Announcement the Important Resolutions in 2022 Annual General Meeting of Shareholders
May 27, 2022
Announcement for the Year 2022 ex-dividend record date on behalf of GRAPE KING BIO's major subsidiary, Pro-Partner Ltd.
April 19, 2022
Announcement for the important resolutions of the 2022 Annual Shareholders' meeting on behalf of GRAPE KING BIO's major subsidiary, Pro-Partner Ltd.
April 19, 2022
Announcement for following local government's COVID-19 preventive measures to extend suspend operation on behalf of Shanghai Grape King Enterprise Co., Ltd.
April 7, 2022
Announcement for following local government's COVID-19 preventive measures to suspend operation from 1-5 April(03：00 AM) on behalf of Shanghai Grape King
March 30, 2022
Announcement of the Company's Consolidated Financial Report for Year 2021 has been approved by the Board of Directors
February 23, 2022
Announcement from the Board of Directors relating to the 2022 Annual Shareholders' meeting
February 23, 2022
Announcement from the Board of Directors regarding Year 2021 earnings distribution
February 23, 2022
Announcement from the Board of Directors regarding earnings distribution on behalf of Shanghai Grape King Enterprise Co., Ltd.
February 23, 2022
Announcement from the Board of Directors regarding earnings distribution on behalf of GRAPE KING INTERNATIONAL INVESTMENT INC.
February 23, 2022
Announcement for increasing the investment constructing of plant in Pingzhen Industrial Park which has been approved by the BOD-the first phase
February 23, 2022
Announcement of the outcome from the BOD meeting regarding Year 2021 earnings distribution on behalf of Grape King Bio's major subsidiary, Pro-Partner Ltd.
February 17, 2022
Announcement from the Board of Directors relating to the 2022 Annual Shareholders' meeting on behalf of Grape King Bio's major subsidiary, Pro-Partner Ltd.
February 17, 2022
Announcement from the Board of Directors relating to a donation to related party on behalf of Grape King Bio's major subsidiary, Pro-Partner Ltd.
February 17, 2022
Grape King Bio: Announcement that the Company has applied to FDA for a Phase II clinical trial review in humans.(IND)
February 11, 2022
Decks in 2022
- Investor Presentation (November 2022)
Investor deck · 43 slides · November 2022
- Investor Presentation (November 2022)
Investor deck · 46 slides · November 2022